ClearanceBrief
Recall Z-0168-2016 ยท IYE Accelerator, Linear, Medical

Siemens Medical Solutions USA, Inc

ONCOR Avant Garde, ONCOR Impression Plus, ONCOR Expression, ONCOR Impression, PRIMUS HI, MEVATRON M2/PRIMUS Mid-Energy, ARTISTE; intended use is to deliver x-ray radiation for therapeutic treatment of cancer.

DateOct 27, 2015 (initiated May 5, 2015)
StatusTerminated
Reasonpotential safety risk of collision of the LINAC gantry with the patient or the treatment table in case of automatically sequenced treatment delivery techniques using SIMTEC" Auto Field Sequence Option.
Root causeSoftware design
ActionSiemens sent Safety Advisory Notices, dated May 5th and 22nd, 2015 to all affected customers to inform them about an update of the Control Console software to correct defects affecting the Control Console with their digital Linear Accelerator. Customers were instructed to ensure everne at their organization is aware of the information in the Advisory Notice. If product was further distributed, please forward Safety Notice to all those affected. For questions regarding this recall call 610-219-6300.
Quantity158
DistributionNationwide Distribution
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K031764ONCOR AVANT-GARDE WITH COHERENCE WORKSPACES
Siemens Medical Solutions USA, Inc., Sep 5, 2003
K060226ONCOR EXPRESSION
Siemens Medical Solutions USA, Inc., Mar 15, 2006
K142434ARTISTE SOLUTION, SYS_VC10C, PHASE 2 UPDATE WITH THE SYNGO RT THERAPIST & RT ONCOLOGIST WORKSPACES, V4.3.1_MR1
Siemens Medical Solutions USA, Inc., Nov 21, 2014
K993425PRIMUS
Siemens Medical Solutions USA, Inc., Nov 26, 1999